000			02322 a2200697 4500
005			20250517074630.0
264		0	_c20170512
008			201705s 0 0 eng d
022			_a1876-4479
024	7		_a10.1093/ecco-jcc/jjw022 _2doi
040			_aNLM _beng _cNLM
100	1		_aCarpio, D
245	0	0	_aTuberculosis in Anti-Tumour Necrosis Factor-treated Inflammatory Bowel Disease Patients After the Implementation of Preventive Measures: Compliance With Recommendations and Safety of Retreatment. _h[electronic resource]
260			_bJournal of Crohn's & colitis _cOct 2016
300			_a1186-93 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Observational Study
650	0	4	_aAdalimumab _xtherapeutic use
650	0	4	_aAdult
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGuideline Adherence _xstatistics & numerical data
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aInflammatory Bowel Diseases _xcomplications
650	0	4	_aInfliximab _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOpportunistic Infections _xcomplications
650	0	4	_aPractice Guidelines as Topic
650	0	4	_aRetreatment
650	0	4	_aRetrospective Studies
650	0	4	_aSpain
650	0	4	_aTreatment Outcome
650	0	4	_aTuberculin Test _xstatistics & numerical data
650	0	4	_aTuberculosis _xcomplications
700	1		_aJauregui-Amezaga, A
700	1		_ade Francisco, R
700	1		_ade Castro, L
700	1		_aBarreiro-de Acosta, M
700	1		_aMendoza, J L
700	1		_aMañosa, M
700	1		_aOllero, V
700	1		_aCastro, B
700	1		_aGonzález-Conde, B
700	1		_aHervías, D
700	1		_aSierra Ausin, M
700	1		_aSancho Del Val, L
700	1		_aBotella-Mateu, B
700	1		_aMartínez-Cadilla, J
700	1		_aCalvo, M
700	1		_aChaparro, M
700	1		_aGinard, D
700	1		_aGuerra, I
700	1		_aMaroto, N
700	1		_aCalvet, X
700	1		_aFernández-Salgado, E
700	1		_aGordillo, J
700	1		_aRojas Feria, M
773	0		_tJournal of Crohn's & colitis _gvol. 10 _gno. 10 _gp. 1186-93
856	4	0	_uhttps://doi.org/10.1093/ecco-jcc/jjw022 _zAvailable from publisher's website
999			_c25661553 _d25661553